CHAI has been working in India since 2004, supporting the government across 13 states to expand access to prevention, diagnosis, management, and treatment services across critical healthcare needs. These include COVID-19; hepatitis; HIV/AIDS; syphilis; tuberculosis; vector borne diseases; antimicrobial resistance; cancer; childhood diarrhea and pneumonia and improving oxygen access; maternal, child, and reproductive health; anemia; immunization; nutrition and safe drinking water; health financing, and disease surveillance.
Over the last two decades, CHAI’s support has focused on program design and planning; behavioral change communication; data analytics; review and governance, research and evidence generation; supply chain management; policy research; capacity building; drugs, devices, and commodities; monitoring and evaluation; inter-agency coordination, and private sector engagement.
Since March 2020, we have assisted the Indian Council of Medical Research (ICMR) and the Department of Health Research (DHR) to rapidly scale-up testing capacity for COVID-19. CHAI has assisted multiple states including Bihar, Madhya Pradesh, Punjab, Uttar Pradesh, and Tamil Nadu, to respond to the pandemic by harmonizing data systems to improve decision making, supply chain and case management, and introduce and scale-up COVID-19 vaccinations. During the pandemic’s peak, CHAI also supported the Ministry of Health and Family Welfare (MoHFW) and select states to improve access to oxygen and assist the health system to meet patient demand. CHAI continues to extend its support to national and state level government agencies to holistically strengthen the COVID-19 response including testing, treatment, vaccination, and surveillance and prepare for future outbreaks.